PTER and colitis: In our previous study, we demonstrated that treatment with the glycosylation product of PTER (pterostilbene 4′-β-glucoside, 4-PG) can attenuate dextran sulfate sodium-induced colitis in mice via upregulation of tristetraprolin (TTP) [14, 15].